EA201890703A1 - Коллоидные частицы, предназначенные для применения в медицине - Google Patents

Коллоидные частицы, предназначенные для применения в медицине

Info

Publication number
EA201890703A1
EA201890703A1 EA201890703A EA201890703A EA201890703A1 EA 201890703 A1 EA201890703 A1 EA 201890703A1 EA 201890703 A EA201890703 A EA 201890703A EA 201890703 A EA201890703 A EA 201890703A EA 201890703 A1 EA201890703 A1 EA 201890703A1
Authority
EA
Eurasian Patent Office
Prior art keywords
medicine
colloid particles
particles intended
composition
intended
Prior art date
Application number
EA201890703A
Other languages
English (en)
Inventor
Уильям Генри
Ричард Вольф-Гаррэвэй
Джон Майо
Original Assignee
Кантаб Биофармасьютикалз Пэтентс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кантаб Биофармасьютикалз Пэтентс Лимитед filed Critical Кантаб Биофармасьютикалз Пэтентс Лимитед
Publication of EA201890703A1 publication Critical patent/EA201890703A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Согласно изобретению предложена композиция для применения в медицине, содержащая коллоидную частицу, содержащую примерно от 0,5 до 20 мол.% амфипатического липида, дериватизированного биосовместимым гидрофильным полимером, причем указанная композиция не содержит какого-либо фармацевтически активного агента.
EA201890703A 2015-10-14 2016-10-14 Коллоидные частицы, предназначенные для применения в медицине EA201890703A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1518172.0A GB201518172D0 (en) 2015-10-14 2015-10-14 Colloidal particles for use in medicine
PCT/EP2016/074759 WO2017064276A1 (en) 2015-10-14 2016-10-14 Colloidal particles for use in medicine

Publications (1)

Publication Number Publication Date
EA201890703A1 true EA201890703A1 (ru) 2018-11-30

Family

ID=55131025

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201890703A EA201890703A1 (ru) 2015-10-14 2016-10-14 Коллоидные частицы, предназначенные для применения в медицине

Country Status (15)

Country Link
US (2) US20190192664A1 (ru)
EP (1) EP3362039A1 (ru)
JP (1) JP7160678B2 (ru)
KR (1) KR20180067616A (ru)
CN (1) CN108472246A (ru)
AU (1) AU2016336929B2 (ru)
BR (1) BR112018007399A2 (ru)
CA (1) CA3036111C (ru)
EA (1) EA201890703A1 (ru)
GB (1) GB201518172D0 (ru)
HK (1) HK1256814A1 (ru)
IL (1) IL258567A (ru)
MX (1) MX2018004445A (ru)
SG (2) SG11201802956RA (ru)
WO (1) WO2017064276A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202111759D0 (en) * 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles
GB202111758D0 (en) * 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles for use in the treatment of haemophilia A
GB202111757D0 (en) * 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles for use in the treatment of haemophilia A

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
CA2168671C (en) 1993-08-06 2007-04-10 Yechezkel Barenholz A method for high loading of vesicles with biopolymeric substances
ATE283034T1 (de) 1998-04-27 2004-12-15 Opperbas Holding Bv Pharmazeutische zusammensetzungen enthaltend faktor viii und neutrale liposomen
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
CA2379060A1 (en) 1999-07-14 2001-01-25 Alza Corporation Neutral lipopolymer and liposomal compositions containing same
US20030232075A1 (en) 2002-05-06 2003-12-18 University Of Minnesota, A Minnesota Corporation Compositions for producing factor Xa
US20070167359A1 (en) * 2003-04-15 2007-07-19 Moshe Baru Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
CA2613705A1 (en) * 2005-06-29 2007-01-04 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic pr0tein-lip1d complexes
EA029132B1 (ru) 2009-06-03 2018-02-28 Секвессам Текнолоджи Холдингс Лимитед Составы в виде везикул для лечения боли, связанной с остеоартритом
NZ598906A (en) 2009-08-21 2014-08-29 Targeted Delivery Technologies Ltd Vesicular formulations
GB201007356D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIIa
GB201007357D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIII
SG11201406492YA (en) 2012-04-16 2014-11-27 Cantab Biopharmaceuticals Patents Ltd Optimised subcutaneous therapeutic agents
EA030650B1 (ru) * 2013-03-08 2018-09-28 Новартис Аг Липиды и липидные композиции для доставки активных агентов

Also Published As

Publication number Publication date
BR112018007399A2 (pt) 2018-10-16
US20190192664A1 (en) 2019-06-27
SG11201802956RA (en) 2018-05-30
CA3036111A1 (en) 2017-04-20
AU2016336929A1 (en) 2018-05-10
JP2018535952A (ja) 2018-12-06
KR20180067616A (ko) 2018-06-20
MX2018004445A (es) 2018-08-14
JP7160678B2 (ja) 2022-10-25
IL258567A (en) 2018-05-31
WO2017064276A1 (en) 2017-04-20
EP3362039A1 (en) 2018-08-22
SG10202010711UA (en) 2020-12-30
HK1256814A1 (zh) 2019-10-04
AU2016336929B2 (en) 2022-09-29
CN108472246A (zh) 2018-08-31
GB201518172D0 (en) 2015-11-25
CA3036111C (en) 2023-06-06
US20210093721A1 (en) 2021-04-01

Similar Documents

Publication Publication Date Title
MX2021007794A (es) Composiciones y metodos para aplicaciones oftalmicas y/u otras aplicaciones.
CL2017001115A1 (es) Formulación estable de proteina en solución que contiene una alta concentración de un anticuerpo anti-vegf.
MX2021006035A (es) Formulaciones cannabinoides estables.
MX2019005287A (es) Lipidos cationicos para suministro de acido nucleico y su preparacion.
EP4279064A3 (en) Drug delivery from hydrogels
SA515361055B1 (ar) نواتج تكتل قابلة للاستنشاق من جسيمات حاملة مسامية وعقار بحجم الميكرون
MX2017003102A (es) Formulacion para inhalacion liquida que comprende rpl554.
EP3686184A3 (en) Ionizable compounds and compositions and uses thereof
MA38399B2 (fr) Formulation sous forme de comprimé, utile pour traiter l'insuffisance cardiaque aiguë et l'insuffisance cardiaque chronique
EA201991299A1 (ru) Приготовление твердых циклодекстриновых комплексов для доставки офтальмологических активных фармацевтических ингредиентов
GEP20217243B (en) Orodispersible dosage unit containing an estetrol component
MX2015015589A (es) Composiciones y metodos para el suministro de agentes activos hidrófobos.
MX2019003988A (es) Formulaciones de nanoparticulas y sus metodos de fabricacion y uso.
EP3513789A3 (en) Prophylactic and therapeutic agents for fgfr3 diseases
GEP20217308B (en) Orodispersible dosage unit containing an estetrol component
MX2017009699A (es) Composicion de suspension oftalmica.
MA40473A (fr) Dispositifs d'administration de médicaments à base d'une silicone catalysée par du platine, et leurs procédés d'utilisation
MX2017000041A (es) Formulaciones de liberacion inmediata disuasivas de abuso que comprenden polisacaridos no celulosicos.
MX2019010852A (es) Nanoparticulas a base de lipidos con estabilidad mejorada.
EA201890703A1 (ru) Коллоидные частицы, предназначенные для применения в медицине
EP3843705C0 (en) PREPARATION OF NANOSUSPENSION COMPRISING NANOCRYSTALS OF ACTIVE PHARMACEUTICAL INGREDIENTS COMPRISING LITTLE OR NO STABILIZING AGENTS
SG10201902407PA (en) Injectable microparticles for hyper-localized release of therapeutic agents
WO2016001905A3 (en) Stable liquid ready-to-use injectable formulation of bortezomib
MX2018000021A (es) Composiciones multifasicas.
IL270159B (en) Preparations containing nanometer particles for the administration of drugs for the treatment of eye diseases